2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
14
Multiple Myeloma
12
Pain, Postoperative
10
Neoplasms
9
Agnosia
8
Lymphoma, Non-Hodgkin
6
Lung Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Cancer Pain
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Lymphoma
4
Leukemia
4
Hodgkin Disease
4
Head and Neck Neoplasms
4
Burkitt Lymphoma
4
Prostatic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Lymphoma, B-Cell
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Hairy Cell
3
Hematologic Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Trigger Finger Disorder
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Philadelphia Chromosome
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Interventions
Dexamethasone
51
Aprepitant
39
Palonosetron
37
Ondansetron
31
Granisetron
22
Calcium Dobesilate
14
fosaprepitant
13
Olanzapine
13
Therapeutics
8
dexamethasone acetate
7
ramosetron
6
netupitant, palosentron drug combination
6
casopitant
6
Tropisetron
6
Cyclophosphamide
6
dexamethasone 21-phosphate
5
Radiotherapy
5
Metoclopramide
5
Doxorubicin
5
netupitant
4
dolasetron
4
Surveys and Questionnaires
4
Dronabinol
4
Acupressure
4
Yoga
3
Vincristine
3
Tablets
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Lorazepam
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vomiting
×
Acetaminophen
×
Clear all
NCT01474304
2016-09-29
IVAC
Swedish Medical Center
Phase 2
Unknown
80 enrolled